跳至主要内容
临床试验/ACTRN12623000514606
ACTRN12623000514606尚未招募3 期

Topical nifedipine for post haemorrhoidectomy pain relief: a randomised, prospective, double-blind placebo trial protocol

Dr Christopher Steen0 个研究点目标入组 60 人开始时间: 2023年5月18日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients over the age of 18 who are planned for 3-column haemorrhoidectomy, by a closed technique, will be recruited by surgeons during either their initial consultation for haemorrhoidectomy surgery or on the day of planned surgery.

排除标准

  • Patients who will not be included in the trial will be those who:
  • i.are under the age of 18
  • ii.are pregnant or breast feeding
  • iii.have concurrent non-haemorrhoidal anorectal disease
  • iv.have a known allergy to nifedipine
  • v.have comorbidities or take medications that are a contra-indication to nifedipine usage
  • vi.have impaired renal function where parecoxib is contra-indicated
  • vii.have a chronic pain condition requiring ongoing regular analgesia
  • viii.cannot provide informed consent
  • ix.cannot have a general anaesthetic

研究者

发起方
Dr Christopher Steen

相似试验

Topical nifedipine for post haemorrhoidectomy pain... | 临床试验